Cargando…
Prevalence and Clinical Characteristics of Refractory Hypertension
BACKGROUND: We aimed to estimate the prevalence of refractory hypertension (RfH) and to determine the clinical differences between these patients and resistant hypertensives (RH). Secondly, we assessed the prevalence of white‐coat RfH and clinical differences between true‐ and white‐coat RfH patient...
Autores principales: | Armario, Pedro, Calhoun, David A., Oliveras, Anna, Blanch, Pedro, Vinyoles, Ernest, Banegas, Jose R., Gorostidi, Manuel, Segura, Julián, Ruilope, Luis M., Dudenbostel, Tanja, de la Sierra, Alejandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779046/ https://www.ncbi.nlm.nih.gov/pubmed/29217663 http://dx.doi.org/10.1161/JAHA.117.007365 |
Ejemplares similares
-
An Update on Refractory Hypertension
por: Matanes, Faris, et al.
Publicado: (2022) -
2021 Spanish Society of Hypertension position statement about telemedicine
por: Gijón-Conde, T., et al.
Publicado: (2021) -
Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study – a randomized controlled trial
por: Oliveras, Anna, et al.
Publicado: (2016) -
Management of patients with resistant hypertension: current treatment options
por: Kumar, Nilay, et al.
Publicado: (2013) -
Clinical utility of fixed-combination telmisartan–amlodipine in the treatment of hypertension
por: Segura, Julian, et al.
Publicado: (2011)